Insud Pharma
Registry sponsor category
Industry
- Other names
- Insud Pharma
- Company name
- Insud Pharma
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (11)
- A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles
- A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Ethinyl Estradiol (EE) Content of TWIRLA® (Levonorgestrel and Ethinyl Estradiol) Transdermal System
- Benznidazole Absorption, Metabolism and Excretion Study
- Bioavailability and Safety of Two Oral Fixed Dose Preparations Containing 18 mg Ivermectin (IVM 18 MG TABLETS, LICONSA S.A., Spain) Versus Reference Dosing (Weight Based) Containing 6 mg Ivermectin (REVECTINA®, Abbott Laboratórios do Brasil Ltda, Brazil)
- Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females
- Ivermectin to Prevent SARS-CoV-2 (COVID-19) Hospitalisation in Subjects Over 50
- LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
- Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas Disease
- Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness
- Safety and Tolerability of Metronidazole Gel 1.3%
- Sublingual Oxytocin for the Prevention of Post-partum Hemorrhage